Search search Menu  Annual Report 2020 Home Investors Annual Report 2020 Investors  banner-img1.jpg Moving forward together Annual Report & Accounts 2020  Download Annual Report FINANCIAL HIGHLIGHTS Previous Adjusted diluted EPS 47.71c Group operating profit $165.3m +7% Adjusted net operating margin 14.3% +30bps Adjusted profit before tax $152m +4% Next OUR RESPONSE TO COVID-19 2 3 4 OUR RESPONSE TO COVID-19 The Covid-19 pandemic has affected all of our lives in some way. UDG Healthcare’s swift action and clear engagement enabled the organisation to withstand challenging circumstances, while continuing to support its key stakeholders. Our Senior Executive Team acted swiftly in the early stages of the outbreak, setting up a cross-functional Global Response Team and implementing a robust plan of action. The Global Response Team remains in place as the pandemic continues to fluctuate across the world. Our response to COVID-19 (PDF) CHAIR’S STATEMENT A year of strength and increased resilience  Download statement (PDF) CHIEF EXECUTIVE'S REVIEW Focus on purpose, pride in people  Download review (PDF) OUR GLOBAL DIVISIONS A global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement and patient solutions. ASHFIELD ADVISORY Commercial strategy; strategic planning; commercial and field force benchmarking; portfolio, licensing, and development strategy; pricing, reimbursement, market access strategy; therapeutic area insight reports ASHFIELD ENGAGE Medical science liaisons, medical information, market access, omnichannel sales, patient engagement programmes, face-to-face, virtual and hybrid events ASHFIELD HEALTH Medical and scientific communications, full service marketing and creative communications, PR, corporate communications, and public affairs, internal communications, brand and launch strategy, data, digital and social media marketing 64% of Group operating profit 13.7% Net operating margin More about Ashfield A global leader in contract packaging, clinical, manufacturing and technology services PACKAGING Commercial packaging solutions in multiple formats, including bottles, blisters, specialty and secondary packaging of injectables. CLINICAL A comprehensive and integrated clinical trial supply and management service, from pre-clinical through to commercialisation. MANUFACTURING Clinical manufacturing services including analytical services, formulation development, over-encapsulation and placebo manufacture, and sterile fill finish. TECHNOLOGY Technology services to support both commercial and clinical packaging including design, serialisation solutions and clinical IRT solutions. 36% of Group operating profit 15.5% Net operating margin More about Sharp DOWNLOAD CENTRE  Download full Annual Report 2020  Download Strategic Report  Download Governance Report  Download Financial Statements POPULAR PAGES At a glance Our divisions Press Releases & News STAY INFORMED Sign up for email alerts GET CONNECTED OFFICE DETAILS UDG Healthcare 20 Riverwalk Citywest Business Campus Citywest Dublin 24 Ireland OTHER UDG HEALTHCARE WEBSITES OneAshfield Ashfield Advisory Ashfield Engage Ashfield Health Sharp As of 2020, UDG Healthcare received an MSCI ESG Rating of AA. © 2021 UDG Healthcare. All rights reserved. Cookie policy Privacy policy Terms & conditions Anti Modern Slavery Policy Supplier Code of Conduct Sitemap MSCI ESG Disclaimer By Emperor By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Cookies Accept All Cookies